ScienceKyverna cell therapy reportedly shows lasting autoimmune benefit
STAT reports that new data show many patients remained off other therapies a year after treatment.
TLDR
STAT reports that new data on Kyverna Therapeutics’ cell therapy show many patients remained off other therapies a year after treatment. The outlet describes the company as one step closer to launching the first cell therapy for an autoimmune disease.
Kyverna cell therapy reportedly shows lasting autoimmune benefit
STAT reports that new data show many patients remained off other therapies a year after treatment.
TLDR
STAT reports that new data on Kyverna Therapeutics’ cell therapy show many patients remained off other therapies a year after treatment. The outlet describes the company as one step closer to launching the first cell therapy for an autoimmune disease.